These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 35523678)
1. Review of delta-8-tetrahydrocannabinol (Δ Tagen M; Klumpers LE Br J Pharmacol; 2022 Aug; 179(15):3915-3933. PubMed ID: 35523678 [TBL] [Abstract][Full Text] [Related]
2. Receptor mechanism and antiemetic activity of structurally-diverse cannabinoids against radiation-induced emesis in the least shrew. Darmani NA; Janoyan JJ; Crim J; Ramirez J Eur J Pharmacol; 2007 Jun; 563(1-3):187-96. PubMed ID: 17362921 [TBL] [Abstract][Full Text] [Related]
3. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids. Janoyan JJ; Crim JL; Darmani NA Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518 [TBL] [Abstract][Full Text] [Related]
4. Chemistry and Pharmacology of Delta-8-Tetrahydrocannabinol. Abdel-Kader MS; Radwan MM; Metwaly AM; Eissa IH; Hazekamp A; ElSohly MA Molecules; 2024 Mar; 29(6):. PubMed ID: 38542886 [No Abstract] [Full Text] [Related]
5. Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity? Fantegrossi WE; Moran JH; Radominska-Pandya A; Prather PL Life Sci; 2014 Feb; 97(1):45-54. PubMed ID: 24084047 [TBL] [Abstract][Full Text] [Related]
6. Different receptor mechanisms underlying phytocannabinoid- versus synthetic cannabinoid-induced tetrad effects: Opposite roles of CB Wang XF; Galaj E; Bi GH; Zhang C; He Y; Zhan J; Bauman MH; Gardner EL; Xi ZX Br J Pharmacol; 2020 Apr; 177(8):1865-1880. PubMed ID: 31877572 [TBL] [Abstract][Full Text] [Related]
7. One-pot heterogeneous synthesis of Δ(3)-tetrahydrocannabinol analogues and xanthenes showing differential binding to CB(1) and CB(2) receptors. Rosati O; Messina F; Pelosi A; Curini M; Petrucci V; Gertsch J; Chicca A Eur J Med Chem; 2014 Oct; 85():77-86. PubMed ID: 25072877 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of agonist-antagonist properties of nitrogen mustard and cyano derivatives of delta 8-tetrahydrocannabinol. Wiley JL; Compton DR; Gordon PM; Siegel C; Singer M; Dutta A; Lichtman AH; Balster RL; Razdan RK; Martin BR Neuropharmacology; 1996; 35(12):1793-804. PubMed ID: 9076759 [TBL] [Abstract][Full Text] [Related]
9. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Pertwee RG Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291 [TBL] [Abstract][Full Text] [Related]
10. AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol-Like Effects in Mice. Wiley JL; Marusich JA; Lefever TW; Antonazzo KR; Wallgren MT; Cortes RA; Patel PR; Grabenauer M; Moore KN; Thomas BF J Pharmacol Exp Ther; 2015 Sep; 354(3):328-39. PubMed ID: 26105953 [TBL] [Abstract][Full Text] [Related]
11. Characterization of cannabinoid agonists and apparent pA2 analysis of cannabinoid antagonists in rhesus monkeys discriminating Delta9-tetrahydrocannabinol. McMahon LR J Pharmacol Exp Ther; 2006 Dec; 319(3):1211-8. PubMed ID: 16943255 [TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor-mediated regulation of intracellular calcium by delta(9)-tetrahydrocannabinol in resting T cells. Rao GK; Zhang W; Kaminski NE J Leukoc Biol; 2004 May; 75(5):884-92. PubMed ID: 14966196 [TBL] [Abstract][Full Text] [Related]
16. Pharmacological profile of a series of bicyclic cannabinoid analogs: classification as cannabimimetic agents. Compton DR; Johnson MR; Melvin LS; Martin BR J Pharmacol Exp Ther; 1992 Jan; 260(1):201-9. PubMed ID: 1309872 [TBL] [Abstract][Full Text] [Related]
17. Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review. McPartland JM; Duncan M; Di Marzo V; Pertwee RG Br J Pharmacol; 2015 Feb; 172(3):737-53. PubMed ID: 25257544 [TBL] [Abstract][Full Text] [Related]
18. [Drug discrimination properties and cytotoxicity of the cannabinoid receptor ligands]. Tomiyama K; Funada M Nihon Arukoru Yakubutsu Igakkai Zasshi; 2012 Jun; 47(3):135-43. PubMed ID: 22894054 [TBL] [Abstract][Full Text] [Related]
19. Similarities and differences upon binding of naturally occurring Δ Raïch I; Rivas-Santisteban R; Lillo A; Lillo J; Reyes-Resina I; Nadal X; Ferreiro-Vera C; de Medina VS; Majellaro M; Sotelo E; Navarro G; Franco R Pharmacol Res; 2021 Dec; 174():105970. PubMed ID: 34758399 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol. Romero J; Berrendero F; García-Gil L; Ramos JA; Fernández-Ruiz JJ J Mol Neurosci; 1998 Oct; 11(2):109-19. PubMed ID: 10096037 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]